Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

NCT03512288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Multivalent
BIOLOGICAL: 13vPnC

Sponsor

Pfizer